{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T13:44:13Z","timestamp":1775223853589,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd005376.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000}}],"reference-count":56,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005376.pub3","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T21:17:07Z","timestamp":1427231827000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Treatment for IgG and IgA paraproteinaemic neuropathy"],"prefix":"10.1002","volume":"2019","author":[{"given":"Abraham CJ","family":"Stork","sequence":"first","affiliation":[{"name":"University Medical Center Utrecht; Brain Center Rudolf Magnus; Utrecht Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael PT","family":"Lunn","sequence":"additional","affiliation":[{"name":"National Hospital for Neurology and Neurosurgery; Department of Neurology and MRC Centre for Neuromuscular Diseases; Queen Square London UK WC1N 3BG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Nobile-Orazio","sequence":"additional","affiliation":[{"name":"Milan University; IRCCS Humanitas Clinical Institute, Neurology 2; Istituto Clinico Humanitas Via Manzoni 56, Rozzano Milan Italy 20089"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolette C","family":"Notermans","sequence":"additional","affiliation":[{"name":"Brain Center Rudolf Magnus, University Medical Center Utrecht; Department of Neurology; Heidelberglaan 100 Utrecht Utrecht Netherlands 3584 CX"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"issue":"21","key":"10.1002\/14651858.CD005376.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1136\/jnnp.57.Suppl.46","article-title":"Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy","volume":"57 Suppl","author":"L\u00e9ger","year":"1994","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/WNL.47.5.1227","article-title":"Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"47","author":"Notermans","year":"1996","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD005376.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s004150050124","article-title":"Pulsed high-dose dexamethasone treatment of polyneuropathy associated with monoclonal gammopathy","volume":"244","author":"Notermans","year":"1997","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s100720070116","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: long-term course and treatment of 60 patients","volume":"21","author":"Sghirlanzoni","year":"2000","journal-title":"Neurological Sciences"},{"issue":"6","key":"10.1002\/14651858.CD005376.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1600-0404.1986.tb04602.x","article-title":"Benign monoclonal IgAK gammopathy associated with polyneuropathy and dysautonomia","volume":"73","author":"Bailey","year":"1986","journal-title":"Acta Neurologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jnnp.56.1.52","article-title":"IgG monoclonal paraproteinaemia and peripheral neuropathy","volume":"56","author":"Bleasel","year":"1993","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD005376.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1212\/WNL.42.6.1157","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy","volume":"42","author":"Bromberg","year":"1992","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1212\/WNL.41.5.617","article-title":"Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"41","author":"Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-510X(99)00049-0","article-title":"Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance","volume":"164","author":"Troia","year":"1999","journal-title":"Journal of the Neurological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1085-9489.2005.0010206.x","article-title":"History of standard scoring, notation, and summation of neuromuscular signs. A current survey and recommendation","volume":"10","author":"Dyck","year":"2005","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD005376.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1529-8027.2010.00278.x","article-title":"European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on the treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - First Edition","volume":"15","author":"Joint Task Force of the EFNS and the PNS","year":"2010","journal-title":"Journal of the Peripheral Nervous System"},{"issue":"10","key":"10.1002\/14651858.CD005376.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/mus.1147","article-title":"Risk factors for haematological malignancy in polyneuropathy associated with monoclonal gammopathy","volume":"24","author":"Eurelings","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s004010100437","article-title":"Sural nerve T cells in demyelinating polyneuropathy associated with monoclonal gammopathy","volume":"103","author":"Eurelings","year":"2002","journal-title":"Acta Neuropathologica"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1212\/01.WNL.0000078103.71192.40","article-title":"Increase of sural nerve T cells in progressive axonal polyneuropathy and monoclonal gammopathy","volume":"61","author":"Eurelings","year":"2003","journal-title":"Neurology"},{"issue":"2-3","key":"10.1002\/14651858.CD005376.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-5728(92)90041-I","article-title":"IgG monoclonal proteins from patients with axonal peripheral neuropathies bind to different epitopes of the 68kDa neurofilament protein","volume":"36","author":"Fazio","year":"1992","journal-title":"Journal of Neuroimmunology"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jnnp.63.2.163","article-title":"Axonal neuropathy associated with monoclonal gammopathy of undetermined significance","volume":"63","author":"Gorson","year":"1997","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1212\/WNL.48.2.321","article-title":"Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy","volume":"48","author":"Gorson","year":"1997","journal-title":"Neurology"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archneur.59.5.766","article-title":"Efficacy of intravenous immunoglobulin in patients with IgG monoclonal gammopathy and polyneuropathy","volume":"59","author":"Gorson","year":"2002","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0021|cit21","unstructured":"Jan Brozek, Andrew Oxman, Holger Sch\u00fcnemann GRADEpro 2008"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0022|cit22","first-page":"139","article-title":"Peripheral neuropathy associated with monoclonal IgG of undetermined significance: clinical, electrophysiologic, pathologic and therapeutic study of 14 cases","volume":"1","author":"Hermosilla","year":"1996","journal-title":"Journal of the Peripheral Nervous System"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0023|cit23","unstructured":"Higgins JPT Altman DG Sterne JAC (editors) Chapter 8: Assessing risk of bias in included studies In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011) March 2011. Available from www.cochrane-handbook.org"},{"issue":"11","key":"10.1002\/14651858.CD005376.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/jca.1024","article-title":"Adverse reactions associated with mobile therapeutic apheresis: analysis of 17,940 procedures","volume":"16(3)","author":"Kiprov","year":"2001","journal-title":"Journal of Clinical Apheresis"},{"issue":"11","key":"10.1002\/14651858.CD005376.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/mus.880141111","article-title":"Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome","volume":"14","author":"Kleyweg","year":"1991","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4613-2065-4_1","article-title":"Plasma cell dyscrasia: definition and diagnostic evaluation","volume-title":"Polyneuropathies associated with plasma cell dyscrasias","author":"Kyle","year":"1987"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0889-8588(18)30348-4","article-title":"Diagnostic criteria of multiple myeloma","volume":"6","author":"Kyle","year":"1992","journal-title":"Hematology\/Oncology Clinics of North America"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0025-6196(12)60015-9","article-title":"'Benign' monoclonal gammopathy-after 20 to 35 years of follow up","volume":"68","author":"Kyle","year":"1993","journal-title":"Mayo Clinic Proceedings"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002827.pub3","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","author":"Lunn","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD005376.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1468-1331.2003.00687.x","article-title":"Polyneuropathy associated with IgG\/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases","volume":"10","author":"Magy","year":"2003","journal-title":"European Journal of Neurology"},{"issue":"1-2","key":"10.1002\/14651858.CD005376.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2004.02.020","article-title":"IgA monoclonal gammopathy of undetermined significance with peripheral neuropathy","volume":"221","author":"Mehndiratta","year":"2004","journal-title":"Journal of Neurological Sciences"},{"issue":"4","key":"10.1002\/14651858.CD005376.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1212\/WNL.54.4.943","article-title":"Psychometric evaluation of a new sensory scale in immune-mediated neuropathies","volume":"54","author":"Merkies","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jnnp.74.1.99","article-title":"Psychometric evaluation of an overall disability scale in immune-mediated neuropathies","volume":"74","author":"Merkies","year":"2003","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mus.10410","article-title":"Comparison between impairment and disability scales in immune-mediated polyneuropathies","volume":"28","author":"Merkies","year":"2003","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD005376.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nmd.2005.12.003","article-title":"131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Narden, The Netherlands","volume":"16(2)","author":"Merkies","year":"2006","journal-title":"Neuromuscular Disorders"},{"issue":"5","key":"10.1002\/14651858.CD005376.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1002\/14651858.CD005376.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1600-0404.1992.tb06033.x","article-title":"Peripheral neuropathy in monoclonal gammopathy of undetermined significance: prevalence and immunopathogenic studies","volume":"85","author":"Nobile-Orazio","year":"1992","journal-title":"Acta Neurologica Scandinavica"},{"issue":"10 Pt 1","key":"10.1002\/14651858.CD005376.pub3-BIB0039|cit39","first-page":"979","article-title":"Neuropathies associated with IgG and IgA monoclonal gammopathy","volume":"158","author":"Nobile-Orazio","year":"2002","journal-title":"Revue Neurologique"},{"issue":"Pt 6","key":"10.1002\/14651858.CD005376.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/brain\/117.6.1385","article-title":"Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities","volume":"117","author":"Notermans","year":"1994","journal-title":"Brain"},{"issue":"Pt 2","key":"10.1002\/14651858.CD005376.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/brain\/119.2.421","article-title":"Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy","volume":"119","author":"Notermans","year":"1996","journal-title":"Brain"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<73::AID-MUS9>3.0.CO;2-5","article-title":"Diagnostic criteria for demyelinating polyneuropathy associated with monoclonal gammopathy","volume":"23","author":"Notermans","year":"2000","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<164::AID-MUS4>3.0.CO;2-Y","article-title":"Long term clinical and neurophysiological follow up of patients with peripheral neuropathy associated with benign monoclonal gammopathy","volume":"23","author":"Ponsford","year":"2000","journal-title":"Muscle & Nerve"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archinte.1975.00330010097013","article-title":"Idiopathic (asymptomatic) monoclonal gammopathies","volume":"135","author":"Ritzmann","year":"1975","journal-title":"Archives of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jcp.35.1.63","article-title":"Monoclonal gammopathies in the adult population of Finistere, France","volume":"35","author":"Saleun","year":"1982","journal-title":"Journal of Clinical Pathology"},{"issue":"3","key":"10.1002\/14651858.CD005376.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1097-4598(200103)24:3<311::AID-MUS1001>3.0.CO;2-A","article-title":"Clinical spectrum of chronic acquired demyelinating polyneuropathies","volume":"24","author":"Saperstein","year":"2001","journal-title":"Muscle & Nerve"},{"issue":"11","key":"10.1002\/14651858.CD005376.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1212\/WNL.43.11.2202","article-title":"Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy","volume":"43","author":"Simmons","year":"1993","journal-title":"Neurology"},{"issue":"Pt 2","key":"10.1002\/14651858.CD005376.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/brain\/118.2.359","article-title":"Long term follow up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy","volume":"118","author":"Simmons","year":"1995","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00401-002-0615-8","article-title":"Anti-neurofilament antibodies in neuropathy with monoclonal gammopathy of undetermined significance produce experimental motor nerve conduction block","volume":"105","author":"Stubbs","year":"2003","journal-title":"Acta Neuropathologica"},{"issue":"6","key":"10.1002\/14651858.CD005376.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/1531-8249(200006)47:6<808::AID-ANA15>3.0.CO;2-8","article-title":"Myelin widenings and MGUS-IgA: an immunoelectronmicroscopic study","volume":"47","author":"Vallat","year":"2000","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004010051193","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinaemia: a peripheral nerve biopsy study in 18 cases","volume":"100","author":"Vital","year":"2000","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1002\/14651858.CD005376.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(93)90297-C","article-title":"Clinical, neurophysiological and immunological evidence of polyneuropathy in patients with monoclonal gammopathies","volume":"114","author":"Vrethem","year":"1993","journal-title":"Journal of the Neurological Sciences"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0404.2009.01259.x","article-title":"Polyneuropathy associated with IgM vs IgG monoclonal gammopathy: comparison between clinical and electrophysiological findings","volume":"122","author":"Vrethem","year":"2010","journal-title":"Acta Neurologica Scandinavica"},{"issue":"7","key":"10.1002\/14651858.CD005376.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/BF00319857","article-title":"The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings","volume":"238","author":"Yeung","year":"1991","journal-title":"Journal of Neurology"},{"issue":"3","key":"10.1002\/14651858.CD005376.pub3-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005376","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","author":"Allen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005376.pub3-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005376.pub2","article-title":"Treatment for IgG and IgA paraproteinaemic neuropathy","author":"Allen","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005376.pub3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T07:03:12Z","timestamp":1706684592000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005376.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":56,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005376.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}